Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid Hemorrhage (ABASH)

This study has been withdrawn prior to enrollment.
(Funding withdrawn. Design not feasible.)
Sponsor:
Information provided by (Responsible Party):
William J Meurer, University of Michigan
ClinicalTrials.gov Identifier:
NCT01232400
First received: November 1, 2010
Last updated: January 7, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)